A first-in-human phase I study to evaluate the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously every three weeks in patients with advanced solid tumors

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 28; no. 15_suppl; p. 3014
Main Authors Weekes, C. D., Hegde, P., Xin, Y., Yu, R., Xiang, H., Beeram, M., Gore, L., Brachmann, R. K., Patnaik, A.
Format Journal Article
LanguageEnglish
Published 20.05.2010
Online AccessGet full text

Cover

Abstract Abstract only
AbstractList Abstract only
Author Xiang, H.
Gore, L.
Xin, Y.
Beeram, M.
Yu, R.
Patnaik, A.
Brachmann, R. K.
Weekes, C. D.
Hegde, P.
Author_xml – sequence: 1
  givenname: C. D.
  surname: Weekes
  fullname: Weekes, C. D.
– sequence: 2
  givenname: P.
  surname: Hegde
  fullname: Hegde, P.
– sequence: 3
  givenname: Y.
  surname: Xin
  fullname: Xin, Y.
– sequence: 4
  givenname: R.
  surname: Yu
  fullname: Yu, R.
– sequence: 5
  givenname: H.
  surname: Xiang
  fullname: Xiang, H.
– sequence: 6
  givenname: M.
  surname: Beeram
  fullname: Beeram, M.
– sequence: 7
  givenname: L.
  surname: Gore
  fullname: Gore, L.
– sequence: 8
  givenname: R. K.
  surname: Brachmann
  fullname: Brachmann, R. K.
– sequence: 9
  givenname: A.
  surname: Patnaik
  fullname: Patnaik, A.
BookMark eNo1kc1q3TAQhUVJoTdJ32G6axe-1U9ky8tL6E8gTUJJoDshy2Os1JaMJN9w36yPV5m0q-HMnHNm8Z2TMx88EvKB0T3jlH5-tmHPaVFc7ZnUaV2WaS8ou3pDdkzypmoaKc_IjjaCV0yJX-_IeUrPtDiUkDvy5wCDiylXzlfjOhsPy2gSwg2kvPYnyAHwaKbVZIQ8IgzrNJ3g1TkHH-wUvJnA-Oy6UPw_7n4-sFrJA3zcdtUmP4HpZ-ddyhixB-dzNEf0YU2lCo8Yy5sxIsIL4u9U7rCY7NDnBC8ujyV9NN6WZAqT6yGvc4jpkrwdzJTw_b95QZ6-fnm8_l7d3n-7uT7cVpbR-qqylNnGoOq4kFbWXdsqZo0SNW8UpbajqjVKoumHpm061fN66Ia6r9HUQ8-EFRekfe21MaQUcdBLdLOJJ82o3hDogkBvCDRX-j8CvSEQfwErPoOR
CitedBy_id crossref_primary_10_1016_j_cell_2013_01_036
crossref_primary_10_1016_j_cllc_2011_03_003
crossref_primary_10_1158_1078_0432_CCR_12_1652
crossref_primary_10_1016_j_ctrv_2013_11_009
crossref_primary_10_1111_j_1476_5381_2011_01777_x
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/jco.2010.28.15_suppl.3014
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 3014
ExternalDocumentID 10_1200_jco_2010_28_15_suppl_3014
GroupedDBID ---
.55
0R~
18M
2WC
34G
39C
3O-
4.4
53G
5GY
5RE
8F7
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
AEGXH
AENEX
AFFNX
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AWKKM
BAWUL
C45
CITATION
CS3
DIK
EBS
EJD
F5P
F9R
FBNNL
FD8
GX1
H13
HZ~
IH2
KQ8
L7B
LSO
MJL
N4W
N9A
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
VH1
VVN
WH7
X7M
YCJ
YFH
YQY
ID FETCH-LOGICAL-c1064-c01c7ae8b235c56b9981ca83627800cb089a85eadf797b8d26fbf6d6ea6fd13c3
ISSN 0732-183X
IngestDate Fri Aug 23 02:51:23 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 15_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1064-c01c7ae8b235c56b9981ca83627800cb089a85eadf797b8d26fbf6d6ea6fd13c3
PageCount 1
ParticipantIDs crossref_primary_10_1200_jco_2010_28_15_suppl_3014
PublicationCentury 2000
PublicationDate 2010-05-20
PublicationDateYYYYMMDD 2010-05-20
PublicationDate_xml – month: 05
  year: 2010
  text: 2010-05-20
  day: 20
PublicationDecade 2010
PublicationTitle Journal of clinical oncology
PublicationYear 2010
SSID ssj0014835
Score 2.001544
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage 3014
Title A first-in-human phase I study to evaluate the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously every three weeks in patients with advanced solid tumors
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkCZeEAwQ3zokNIE6h8aJE_ex2kAraFOFOql7iuzEgfLRTKwVKn8Z_xmvnO04SRkI2EvUusnJ8f16Pp_PvyPkaaS1jEKlaFTqlMYlk1QlMqVSyhgXQbosmTmcfHScHJ7Er2d81uv96GQtrZYqyL_99lzJZbSKbahXc0r2PzTbCMUG_Iz6xStqGK__pONRv5yj90bnC-pq7Z29x0mpP3akscatrMm8tfUvTah9XVflwz5W-ScbBsSxnasK7z86fjsJE8FHxu00rdQ0mLiBrCl2TWFPwzBhahYZblcUp3HU1qbcj9b9r1p_dHnpjq3VH53zeQY4GvOiv1x9ruo9pItecXNSs1rkmxF_lO1M2n7QPwjaGO47Rxw8aZpmjhbhtGk4XVkgBd0Ih9ucZ4OOIUwjRtH0zNycVRtqluLKwFH8ekvORBexPDs3hVE71tksHzszvf96YRZhtkD2h7xyqX9MBF5Y0IroMnf_MqM2eY5mhYXCMhSVGVEZE5kXlRlRV8hVhhbS5CIejN8021-xcJVh_Ytvkyd1v178sVcdx6rjIU1vkOu1EmHkcHqT9PRih2wf1ckbO2R34mjS13swbU_9ne_BLkxaAvX1LfJ9BJu4BotrGIPFNSwr8LgGxDVYXIO7s8U1eFxDg2t41qD6OXQxDRuYBotpsJgGi2n8HTymwWAaPKbBYhocpm-Tk1cvp_uHtK4wQvMQfXGaD8I8lVooFvGcJ2o4FGEuBTp1KS6kcjUQQyk4GtsyHaZKFCwpVZkUiZZJWYRRHt0hW4tqoe8SGHJeJEWsuNA81uj241PGPZYalxS8TO4R5tWTnTkimeyv8Lh_mYcekGvtv-gh2Vp-WelH6Dkv1WOLsp-_E8mE
link.rule.ids 315,783,787,27938,27939
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+first-in-human+phase+I+study+to+evaluate+the+fully+human+monoclonal+antibody+MNRP1685A+%28anti-NRP1%29+administered+intravenously+every+three+weeks+in+patients+with+advanced+solid+tumors&rft.jtitle=Journal+of+clinical+oncology&rft.au=Weekes%2C+C.+D.&rft.au=Hegde%2C+P.&rft.au=Xin%2C+Y.&rft.au=Yu%2C+R.&rft.date=2010-05-20&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=28&rft.issue=15_suppl&rft.spage=3014&rft.epage=3014&rft_id=info:doi/10.1200%2Fjco.2010.28.15_suppl.3014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2010_28_15_suppl_3014
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon